LAZMA Cream is indicated for the short‐term (up to 8 weeks)
treatment of moderate to severe melasma of the face in the presence of
measures for sun avoidance, including the use of sunscreens.Adverse Events:
In the controlled clinical trials, the most frequently reported events were
redness, peeling, burning, dryness, and itching at the site of application.

Lazma Cream  – Melasma  is a common skin condition in which
light to dark brown or grayish pigmentation develops, mainly on the face,
less commonly on forearms and neck, due to overproduction of melanin by the
pigment cells, melanocytes.